(from now on referred to as "umbrella review") 9 on various types of TT used with children with motor impairments summarizing the results of five systematic reviews published between 2006 and 2009 [10] [11] [12] [13] [14] as well as a 2011 Cochrane systematic review 15 on PBWSTT in zero to six year old children at risk for neuromotor delays . Table 1 summarizes these studies as well as the higher level publications included in the overview and Cochrane review.
No negative outcomes were reported in any of the reviews or studies using non-robotic TT; however, many individual studies did not report the presence or absence of adverse outcomes in their research. One large level IV study utilizing robotic TT did mention that 43% of participants did report an adverse event (muscle pain, joint pain, skin erythema, open skin lesions and tendinopathy) but that these were clinically insignificant in that they did not interfere with treatment. 6 In an effort to report all study outcomes in a similar manner, and since many studies had sample sizes that were too small to allow for statistical analysis or to detect significant differences, outcomes in this summary are reported as positive if there was a trend toward better outcomes or if more than half of the sample achieved positive gains. Results that were statistically significant are represented in bold. Results that were inconclusive or showed no changes are combined in one column (see Tables 2-5 ).
Cerebral Palsy
A high number of studies regarding the use of different varieties of TT have been conducted in children with CP (see Table 2 ). [6] [7] [8] [16] [17] [18] [19] [20] The levels of evidence of these studies continue to mostly be at a level of IV or V, however two level II randomized controlled trials (RCTs) 16, 17 and one level III study 18 have examined the use of PBWSTT in children with CP. Overall results from these high level studies as well as those synthesized in the overview and Cochrane review are conflicting in both the Body Structure and Function (BS&F) and Activities and Participation (A&P) dimensions of the ICF. In particular, improvements in gait, aerobic capacity and functional mobility show the most mixed results between studies. In addition, the two recently published level II RCTs reported no advantage of PBWSTT over overground walking or strength training in improving outcomes; 16, 17 both studies may have been underpowered to detect significant differences between groups due to the smaller than expected sample size. However, these results are in line with the findings for the 0-6 year old population included in the Cochrane review as well as the umbrella review. 9, 15 One level II RCT examined the use of TT with neuromuscular electrical stimulation (NMES) in children with CP and found improvements in dimensions D and E of the Gross Motor Function Measure (GMFM). 19 In addition Kurz et al. examined the use of a novel mode of TT, LBPPSTT, in children with CP (level IV) and found that this intervention might have a positive impact on various parameters of BS&F including gait, lower extremity strength and balance. 8 Two level IV studies also examined the use of robotic PWBSTT and both determined that robotic PBWSTT might be effective in improving GMFM dimensions D and E. 6, 20 Lastly, Smania et al completed a level II RCT evaluating the use of a novel gait trainer and determined that individuals who participated in the gait trainer program had significantly improved outcomes in their 6-minute walk tests than their counterparts who completed conventional physiotherapy sessions; this difference was maintained one month post-intervention. 
Down Syndrome
A number of high level studies support the use of TT in children with DS (see Table 3 ). [21] [22] [23] [24] [25] [26] [27] These results are corroborated by the results of the TT umbrella review and recent Cochrane review. 9, 15 Multiple studies (level II) albeit from only two samples, suggest a number of statistically significant results in gait parameters as well as age of onset of walking when using TT only in infants with DS [21] [22] [23] [24] [25] [26] and with better results when not wearing supra-malleolar orthotics. 27 However, a significant lack of evidence exists regarding the effects of TT on A&P in these children, an important gap in currently available research.
Spina Bifida
Promising results have been published very recently in two studies (level II 28 and level V 29 ) evaluating the use of TT in children with SB (see Table 4 ). The level II study reported statistically significant short and longer-term effects in BS&F outcomes. 28 The level V study's results suggest that the toddler achieved functional walking on the earlier end of the spectrum than what is reported for children with his or her level of impairment in addition to other improvements in BS&F outcomes.
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Spinal Cord Injury
Research regarding the effectiveness of different types of TT in children with SCI is beginning to emerge (four recent level IV & V studies) and results of the original studies which are also corroborated in the TT umbrella review 9 suggest positive results may be possible for A&P outcomes albeit receiving mixed results for BS&F outcomes (see Table 5 ).
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What parameters and protocols should be used?
Cerebral Palsy
In terms of parameters of intervention, studies have been highly variable in their use of different types of TT, speed, BWS, time per session, frequency, and duration. [6] [7] [8] [16] [17] [18] [19] [20] It is therefore difficult to suggest which parameters might be responsible for creating positive outcomes. Level II & III studies used various modes of TT for four to 12 weeks, two to five times per week, one to two times per day with BWS starting at approx 40 % and reduced to as close to 0%, and highly variable speeds. 6, 7, [16] [17] [18] [19] [20] 
Down Syndrome
Intervention parameters in this population have been quite consistent and suggest that intervention using a speed of approximately 20 cm/s (0.72km/hr or 0.45 miles/hr) for six to nine minutes, five to seven days per week until the achievement of independent walking can have important effects on BS&F.
21-27
Spina Bifida
Research surrounding the use of TT in this population is very limited, however, the level II study included a TT program consisting of 21-32 minute sessions, two times per week for 12 weeks. 28 The level V study involved using TT with progressive use of a walker to achieve functional walking in a toddler with an L4-L5 level lesion. 29 TT consisted of the child being held over the treadmill by a parent a minimum of five times per week for a total of 25 minutes per week for 18 weeks.
Spinal Cord Injury
All studies pertaining to SCI utilized one or more modes of PBWSTT with a BWS percentage starting around 40-80% and decreasing as the intervention period progressed. Intervention was three or more times per week for greater than eight weeks in duration. [30] [31] [32] [33] Can treadmill training be recommended for children with motor impairments?
Based on outcomes from the highest available level of evidence publications, grades of recommendation can be offered for each diagnostic group and form of TT; grades are defined in Appendix IV 34 and TT recommendations are summarized in Figure 1 . In summary, no adverse events have been reported when using TT in pediatric populations. With the exception of children with Down syndrome, due to the lower levels of evidence and conflicting results in the TT literature, it is recommended that clinicians choosing to use TT measure meaningful client and family outcomes to ensure that the intervention is having the desired effect. 
